91 related articles for article (PubMed ID: 16549694)
1. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
2. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging.
Bronstein Y; Ng CS; Rohren E; Ross MI; Lee JE; Cormier J; Johnson VE; Hwu WJ
AJR Am J Roentgenol; 2012 Apr; 198(4):902-8. PubMed ID: 22451559
[TBL] [Abstract][Full Text] [Related]
3. PET/CT imaging: detection of choroidal melanoma.
Reddy S; Kurli M; Tena LB; Finger PT
Br J Ophthalmol; 2005 Oct; 89(10):1265-9. PubMed ID: 16170113
[TBL] [Abstract][Full Text] [Related]
4. Utilization of Imaging Modalities in the Diagnosis of Melanoma: A Scoping Review.
Shapiro L; Basra M; Patel H; Payne C; Brazen B; Biglione A
Cureus; 2024 Feb; 16(2):e54058. PubMed ID: 38481925
[TBL] [Abstract][Full Text] [Related]
5. Total-Body PET: Will It Change Science and Practice?
Pantel AR; Mankoff DA; Karp JS
J Nucl Med; 2022 May; 63(5):646-648. PubMed ID: 35273091
[No Abstract] [Full Text] [Related]
6. Diagnostic Performance of [
Zamani-Siahkali N; Mirshahvalad SA; Pirich C; Beheshti M
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201642
[TBL] [Abstract][Full Text] [Related]
7. Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20-22 February 2020.
Lee CW; McKinnon JG; Davis N
Curr Oncol; 2021 May; 28(3):2040-2051. PubMed ID: 34072050
[No Abstract] [Full Text] [Related]
8. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Chest Radiographs and Laboratory Testing during Melanoma Staging Procedures.
Brooks WC; Votanopoulos KI; Russell GB; Shen P; Levine EA
Am Surg; 2019 May; 85(5):505-510. PubMed ID: 31126364
[TBL] [Abstract][Full Text] [Related]
10. Melanoma & nuclear medicine: new insights & advances.
Perissinotti A; Rietbergen DD; Vidal-Sicart S; Riera AA; Olmos RAV
Melanoma Manag; 2018 Jun; 5(1):MMT06. PubMed ID: 30190932
[TBL] [Abstract][Full Text] [Related]
11. Melanoma and nuclear medicine.
Perissinotti A; Vidal-Sicart S; Nieweg O; Valdés Olmos R
Melanoma Manag; 2014 Aug; 1(1):57-74. PubMed ID: 30190811
[TBL] [Abstract][Full Text] [Related]
12. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
13. Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.
Danielsen M; Kjaer A; Wu M; Martineau L; Nosrati M; Leong SP; Sagebiel RW; Miller JR; Kashani-Sabet M
Am J Nucl Med Mol Imaging; 2016; 6(5):277-285. PubMed ID: 27766186
[TBL] [Abstract][Full Text] [Related]
14. Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part II.
Castro LG; Bakos RM; Duprat Neto JP; Bittencourt FV; Di Giacomo TH; Serpa SS; Messina MC; Loureiro WR; Macarenco RS; Stolf HO; Gontijo G
An Bras Dermatol; 2016; 91(1):49-58. PubMed ID: 26982779
[TBL] [Abstract][Full Text] [Related]
15. Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).
Guo J; Qin S; Liang J; Lin T; Si L; Chen X; Chi Z; Cui C; Du N; Fan Y; Gu K; Li F; Li J; Li Y; Liang H; Liu J; Lu M; Lu A; Nan K; Niu X; Pan H; Ren G; Ren X; Shu Y; Song X; Tao M; Wang B; Wei W; Wu D; Wu L; Wu A; Xu X; Zhang J; Zhang X; Zhang Y; Zhu H; ;
Ann Transl Med; 2015 Dec; 3(21):322. PubMed ID: 26734632
[No Abstract] [Full Text] [Related]
16. Successful treatment of triple primary tumor.
Kurul S; Akgun Z; Saglam EK; Basaran M; Yucel S; Tuzlali S
Int J Surg Case Rep; 2013; 4(11):1013-6. PubMed ID: 24091078
[TBL] [Abstract][Full Text] [Related]
17. Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.
Mozzillo N; Caracò C; Marone U; Di Monta G; Crispo A; Botti G; Montella M; Ascierto PA
World J Surg Oncol; 2013 Feb; 11():36. PubMed ID: 23379355
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma.
Ortega Candil A; Rodríguez Rey C; Carreras Delgado JL
ISRN Dermatol; 2012; 2012():308279. PubMed ID: 23259071
[TBL] [Abstract][Full Text] [Related]
19. Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma.
Arrangoiz R; Papavasiliou P; Stransky CA; Yu JQ; Tianyu L; Sigurdson ER; Berger AC; Farma JM
Dermatol Res Pract; 2012; 2012():614349. PubMed ID: 22654898
[TBL] [Abstract][Full Text] [Related]
20. Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature.
Mirk P; Treglia G; Salsano M; Basile P; Giordano A; Bonomo L
Radiol Res Pract; 2011; 2011():912504. PubMed ID: 22242204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
